Skip to main content

Pesicka Edward A's Form 4 filing

Accendra Health IncACH · filed Nov 4, 2021

Accession no.
0001062993-21-010283
Filed
Nov 4, 2021
Trade date
Nov 3, 2021
Filing delay
1 day
Rule 10b5-1 plan
Not on the form (before 2023)

This filing lists 3 non-derivative transactions. Open-market sales total $2.38M. It was filed 1 day after the trade.

Reporting owners

A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.

Reporting owners on this filing
OwnerRelationship to the company
Pesicka Edward ACIK 0001439487Director, Officer (President & CEO)

Non-derivative securities (Table I)

Acquisitions and disposals of common stock and similar shares, one row per line on the filing.

Non-derivative transactions
Trade dateSecurityTransactionSharesPriceValueShares afterOwnershipFlags
Nov 3, 2021Common StockSSaleDisposed−3,598$40.31F2−$145,035.381,316,828Direct
Nov 3, 2021Common StockSSaleDisposed−23,728$41.63F3−$987,796.641,293,100Direct
Nov 3, 2021Common StockSSaleDisposed−29,315$42.46F4−$1,244,714.91,263,785Direct

Footnotes and remarks

Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.

F2

Weighted average of the sale price range of $40.00 through $40.90

Referenced by the price of 1 transaction in Table I.

F3

Weighted average of the sale price range of $41.11 through $42.10

Referenced by the price of 1 transaction in Table I.

F4

Weighted average of the sale price range of $42.12 through $42.90

Referenced by the price of 1 transaction in Table I.

Read the full filing on SEC EDGAR (opens in a new tab)